Animal Health

Yuyu Pharma's quiet entry into the U.S. isn't just about cat supplements. It's a masterclass in strategic infiltration, using a UCLA incubator to de-risk a billion-dollar bet.

A special dividend from a £235M private equity deal signals VCT success, but a closer look at the fund's performance reveals a more complex picture.

A pet supplement startup just cracked the top 1000 of the Inc. 5000 list. Their secret? Replacing vague marketing with verifiable science and radical transparency.

Wagmo's rapid growth on the Inc. 5000 isn't just about pets. It signals a strategic shift in employee benefits and a new definition of corporate care.

The vet telehealth startup ranked No. 120 on the Inc. 5000, revealing how digital innovation is tackling a nationwide shortage of pet care.

With at-home PCR tests and AI-driven insights, Petwealth is building a decentralized health network for pets, challenging the traditional vet care model.

A landmark study on equicenta® CTM shows it nearly triples a horse's odds of returning to performance, offering a ready-to-use solution that challenges the status quo.

ADM's award-winning postbiotic, PRIOME® MH, is revolutionizing canine care by addressing metabolic health at its root, moving beyond traditional diet and exercise.

Zesty Paws' award-winning diffuser is more than a pet product; it's a signal of a tech-driven shift in the booming pet wellness industry.

The 2026 Pet Innovation Awards highlight a market in transformation. It’s no longer just about food and toys, but a tech-driven wellness ecosystem.

A South Korean pet health firm's U.S. sales surged 850%. Now, armed with breakthrough AIM science, Greycoat Research is making its biggest move yet.

Biotech firm Kindred Companion Sciences has used CRISPR to create two beagles free of the main allergen, offering hope to millions but raising complex ethical questions.

A partnership between Trupanion and Digitail isn't just software. It's a blueprint for tackling veterinary burnout and revolutionizing pet healthcare access.

The first Animal Longevity Summit marks a pivotal moment, as research into pet aging and biotech investment converge to create a new frontier in healthspan.

A recall of a vital pet arthritis drug due to glass fibers reveals a history of quality control failures, forcing a difficult reckoning for pet owners and vets.

PetIQ's acquisition of MYOS Corp and its muscle-preserving Fortetropin® signals a major shift in the booming pet wellness market toward science-backed longevity.

Royal Canin's new Amazon partnership is more than a convenience play; it's a calculated move by Mars to dominate the booming pet health e-commerce space.

A new acquisition merges veterinary science with vision-AI, creating a 'digital twin' for pets that analyzes behavior to offer proactive nutritional care.

Leveraging its global dominance in human medicine, Jiangxi Bio is entering the booming veterinary market with a new production line, a key move in its growth strategy.

Halo Collar's move to bundle 24/7 vet care is more than a new feature. It's a calculated play to build an inescapable pet care ecosystem and redefine value.